Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eosinophilic Esophagitis | 7 | 2023 | 205 | 3.170 |
Why?
|
Budesonide | 6 | 2024 | 162 | 1.460 |
Why?
|
Deglutition Disorders | 3 | 2023 | 640 | 1.270 |
Why?
|
Suspensions | 5 | 2024 | 68 | 0.770 |
Why?
|
Bariatric Surgery | 4 | 2020 | 1001 | 0.670 |
Why?
|
Dyslipidemias | 3 | 2019 | 873 | 0.530 |
Why?
|
Alanine Transaminase | 1 | 2019 | 606 | 0.520 |
Why?
|
Lipoproteins, IDL | 1 | 2015 | 18 | 0.500 |
Why?
|
Apolipoprotein A-II | 1 | 2015 | 41 | 0.500 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 157 | 0.470 |
Why?
|
Lipoproteins, VLDL | 1 | 2015 | 201 | 0.460 |
Why?
|
Fatty Liver | 2 | 2016 | 809 | 0.400 |
Why?
|
Obesity, Morbid | 3 | 2020 | 1298 | 0.400 |
Why?
|
Elasticity Imaging Techniques | 1 | 2016 | 398 | 0.360 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 3251 | 0.320 |
Why?
|
Perioperative Care | 1 | 2015 | 1043 | 0.290 |
Why?
|
Triglycerides | 1 | 2015 | 2464 | 0.280 |
Why?
|
Weight Loss | 2 | 2016 | 2721 | 0.280 |
Why?
|
Adolescent Behavior | 1 | 2015 | 1186 | 0.270 |
Why?
|
Food-Drug Interactions | 1 | 2024 | 26 | 0.240 |
Why?
|
Esophagoscopy | 2 | 2023 | 398 | 0.230 |
Why?
|
Patient Selection | 1 | 2015 | 4260 | 0.210 |
Why?
|
Gastroenterology | 2 | 2020 | 593 | 0.210 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2022 | 75 | 0.190 |
Why?
|
Alagille Syndrome | 1 | 2021 | 45 | 0.190 |
Why?
|
Pruritus | 2 | 2022 | 379 | 0.190 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 640 | 0.180 |
Why?
|
Liver | 1 | 2016 | 7577 | 0.170 |
Why?
|
Bariatrics | 1 | 2020 | 36 | 0.170 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 879 | 0.160 |
Why?
|
Cholestasis | 1 | 2022 | 385 | 0.160 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2107 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 938 | 0.150 |
Why?
|
Adolescent | 13 | 2023 | 89169 | 0.140 |
Why?
|
Liver Function Tests | 1 | 2019 | 526 | 0.140 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2011 | 390 | 0.140 |
Why?
|
Glucocorticoids | 2 | 2023 | 2167 | 0.130 |
Why?
|
Double-Blind Method | 4 | 2023 | 12465 | 0.130 |
Why?
|
Child | 12 | 2023 | 80917 | 0.130 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 62 | 0.120 |
Why?
|
Creatine Kinase | 1 | 2017 | 684 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 354 | 0.120 |
Why?
|
Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 14 | 0.120 |
Why?
|
Hepatomegaly | 1 | 2014 | 84 | 0.110 |
Why?
|
Blood-Brain Barrier | 2 | 2011 | 1034 | 0.110 |
Why?
|
Apolipoprotein C-III | 1 | 2015 | 210 | 0.110 |
Why?
|
Obesity | 1 | 2015 | 13090 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2017 | 553 | 0.100 |
Why?
|
Qualitative Research | 1 | 2023 | 3140 | 0.100 |
Why?
|
Humans | 27 | 2024 | 768166 | 0.100 |
Why?
|
Diet, Reducing | 1 | 2015 | 487 | 0.100 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3711 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2023 | 65371 | 0.090 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2011 | 118 | 0.090 |
Why?
|
Administration, Oral | 3 | 2024 | 4030 | 0.090 |
Why?
|
Male | 16 | 2024 | 364719 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1461 | 0.080 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1145 | 0.080 |
Why?
|
Female | 16 | 2024 | 397192 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.080 |
Why?
|
Kinetics | 1 | 2015 | 6329 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1305 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2403 | 0.070 |
Why?
|
Pediatrics | 2 | 2019 | 3629 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10399 | 0.070 |
Why?
|
Biopsy | 1 | 2016 | 6793 | 0.060 |
Why?
|
Biological Availability | 1 | 2024 | 389 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3706 | 0.050 |
Why?
|
Astrocytes | 1 | 2011 | 1350 | 0.050 |
Why?
|
Leukocytes | 1 | 2010 | 2035 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10590 | 0.050 |
Why?
|
Cohort Studies | 1 | 2023 | 41754 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.040 |
Why?
|
Area Under Curve | 1 | 2024 | 1643 | 0.040 |
Why?
|
Enteritis | 1 | 2021 | 164 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5953 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 398 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15454 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 321 | 0.040 |
Why?
|
Gastritis | 1 | 2021 | 199 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 315 | 0.040 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2022 | 567 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9495 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 615 | 0.040 |
Why?
|
Competency-Based Education | 1 | 2020 | 226 | 0.040 |
Why?
|
Fasting | 1 | 2024 | 1610 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2011 | 3589 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7454 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15948 | 0.040 |
Why?
|
Seizures | 1 | 2010 | 2998 | 0.030 |
Why?
|
Prospective Studies | 2 | 2019 | 54926 | 0.030 |
Why?
|
Eosinophilia | 1 | 2021 | 556 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.030 |
Why?
|
Young Adult | 2 | 2024 | 60066 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223646 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 24315 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9374 | 0.030 |
Why?
|
Infant | 4 | 2021 | 36535 | 0.030 |
Why?
|
Transfection | 2 | 2011 | 5755 | 0.030 |
Why?
|
Child, Preschool | 4 | 2021 | 42669 | 0.030 |
Why?
|
Collagen | 1 | 2000 | 2643 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1805 | 0.020 |
Why?
|
Neurons | 1 | 2011 | 9514 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2000 | 2146 | 0.020 |
Why?
|
Evans Blue | 1 | 2010 | 42 | 0.020 |
Why?
|
Pilocarpine | 1 | 2010 | 64 | 0.020 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 58 | 0.020 |
Why?
|
Carbamazepine | 1 | 2011 | 224 | 0.020 |
Why?
|
Benchmarking | 1 | 2016 | 1057 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1444 | 0.020 |
Why?
|
Albumins | 1 | 2010 | 577 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
Gene Deletion | 1 | 2014 | 2675 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2048 | 0.020 |
Why?
|
Cytokines | 1 | 2000 | 7453 | 0.020 |
Why?
|
Drug Resistance | 1 | 2011 | 1599 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2065 | 0.010 |
Why?
|
Clinical Competence | 1 | 2020 | 4858 | 0.010 |
Why?
|
Brain | 1 | 2011 | 27360 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12077 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1042 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4786 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12543 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4283 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2011 | 1923 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13490 | 0.010 |
Why?
|
Mitogens | 1 | 2000 | 229 | 0.010 |
Why?
|
Rats | 2 | 2010 | 23760 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8128 | 0.010 |
Why?
|
Osteopontin | 1 | 2000 | 306 | 0.010 |
Why?
|
Culture Media | 1 | 2000 | 898 | 0.010 |
Why?
|
Hyaluronic Acid | 1 | 2000 | 484 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15832 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9523 | 0.010 |
Why?
|
Electroencephalography | 1 | 2010 | 6314 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12795 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2000 | 2219 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2000 | 1738 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2000 | 3160 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18349 | 0.010 |
Why?
|
United States | 1 | 2019 | 73039 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223492 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 30238 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74944 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 81762 | 0.000 |
Why?
|
Cell Line | 1 | 2000 | 15597 | 0.000 |
Why?
|
Animals | 2 | 2010 | 169246 | 0.000 |
Why?
|
Mice | 1 | 2000 | 82029 | 0.000 |
Why?
|
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_